Enoxaparin

Prescription ·Strong evidence ·Reviewed May 2026

Enoxaparin is a low-molecular-weight heparin used for prevention and treatment of deep vein thrombosis and pulmonary embolism, as well as in acute coronary syndromes. It is the most widely used LMWH and has more predictable pharmacokinetics than unfractionated heparin, allowing weight-based dosing with fewer monitoring requirements.

What it's good for
  • Effective DVT/PE prevention and treatment6,8
  • Predictable dose-response allows weight-based dosing
  • Subcutaneous administration for outpatient use
  • Bridge therapy to warfarin
  • Acute coronary syndrome management10
What to watch for
  • Bleeding
  • Injection site bruising and pain
  • Thrombocytopenia (HIT, rare but serious)
  • Active major bleeding10
  • History of heparin-induced thrombocytopenia (HIT) with enoxaparin

The bottom line

Evidence rating strong. Most-documented uses: effective dvt/pe prevention and treatment, predictable dose-response allows weight-based dosing, subcutaneous administration for outpatient use. 10 sources indexed (2018–2023), with 5 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Binds to antithrombin III (AT-III) via a specific pentasaccharide sequence, enhancing AT-III's ability to inactivate factor Xa (primarily) and thrombin (factor IIa) to a lesser extent. The anti-Xa to anti-IIa ratio is approximately 3.8:1, compared to 1:1 for unfractionated heparin. This preferential anti-Xa activity provides effective anticoagulation with a lower bleeding risk profile.

Class
Low-Molecular-Weight Heparin (LMWH)
Dosing

Dosing & protocol.

Common range
Prophylaxis: 30 mg SC q12h or 40 mg SC daily; Treatment: 1 mg/kg SC q12h or 1.5 mg/kg SC daily (as prescribed by your physician)
Recommended form
Subcutaneous injection (prefilled syringes)

Administered subcutaneously only (do not give IM); bioavailability approximately 100% via SC route

Safety

Full safety detail.

Side effects

  • Bleeding
  • Injection site bruising and pain
  • Thrombocytopenia (HIT, rare but serious)
  • Elevated liver transaminases
  • Anemia
  • Osteoporosis (with long-term use)

Contraindications

  • Active major bleeding10
  • History of heparin-induced thrombocytopenia (HIT) with enoxaparin
  • Hypersensitivity to enoxaparin, heparin, or pork products1,2
  • Active peptic ulcer or recent hemorrhagic stroke
Interactions

Interaction records.

SeriousCaution

Potassium

Enoxaparin and other heparins suppress adrenal aldosterone production, reducing renal potassium excretion and raising serum potassium. Adding potassium supplements (or potassium-containing salt substitutes) on top of this can produce clinically significant hyperkalemia, especially in patients with diabetes, renal impairment, or on ACE inhibitors, ARBs, or trimethoprim.

Recommendation: Avoid potassium supplements and potassium-based salt substitutes while on enoxaparin unless prescribed and monitored. If you must take potassium, ask for serum potassium to be checked within 3-5 days of starting enoxaparin and weekly thereafter.

ModerateCaution

Fish Oil

Fish oil's omega-3 fatty acids reduce platelet thromboxane A2 and prolong bleeding time. Added to enoxaparin's anti-factor Xa activity, high-dose fish oil (more than 3 g/day EPA+DHA) can additively raise bleeding risk, particularly around surgery or invasive procedures.

Recommendation: Keep fish oil dose modest (≤2 g/day combined EPA+DHA) while on enoxaparin and keep the dose constant. Stop fish oil at least 7 days before any planned procedure and tell your prescriber if you notice unusual bruising or bleeding.

ModerateCaution

Garlic Extract

Concentrated garlic supplements inhibit platelet aggregation through allicin and related compounds and have been linked to perioperative bleeding. Added to enoxaparin's anti-factor Xa activity, garlic supplements can additively raise bleeding risk. Dietary garlic is not a concern.

Recommendation: Avoid concentrated garlic supplements while on enoxaparin, especially if you are receiving treatment doses or are perioperative. Stop garlic supplements at least 7 days before any planned surgery. Cooking with garlic is fine.

SeriousCaution

Ginkgo Biloba

Ginkgo biloba inhibits platelet-activating factor and platelet aggregation, and case reports link it to spontaneous bleeding. Combined with enoxaparin, the antiplatelet effect adds to anti-factor Xa activity and raises bleeding risk.

Recommendation: Avoid ginkgo biloba while on enoxaparin. If you have been combining them, stop the ginkgo and call your prescriber if you notice unusual bruising, nosebleeds, or any sign of bleeding.

DangerousCaution

Nattokinase

Nattokinase has fibrinolytic activity and can reduce clotting factor levels. Enoxaparin potentiates antithrombin activity against factor Xa, so the combination may substantially weaken clotting through separate mechanisms. The risk is highest after surgery, with kidney impairment, or when other antiplatelet or anticoagulant drugs are present.

Recommendation: Avoid nattokinase while using enoxaparin. If the combination has already been used, stop nattokinase and watch for bruising, nosebleeds, black stools, blood in urine, severe headache, or sudden weakness.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

5
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Enoxaparin in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.